Skip to main content

Table 3 Quantitative 18F-Flutemetamol PET SUVr in different cortical regions

From: No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study

Casesprecuneus and posterior cingulate combinedanterior cingulateprefrontalinferior parietallateral temporalComposite
SUVr
1 
2 
30.820.700.600.640.550.65
4 
50.480.470.460.460.440.50
60.550.560.520.510.510.57
70.540.480.480.480.480.54
80.540.520.500.510.490.55
90.850.680.680.750.650.74
10 
110.520.510.490.490.480.54
121.241.211.211.141.161.13
130.540.490.500.510.490.55
14 
150.510.480.470.490.470.53
160.570.540.510.530.500.57
170.640.640.560.590.570.63
180.590.630.570.530.510.58
190.510.500.460.470.460.52
200.480.450.440.450.430.49
210.500.480.460.460.460.51
220.510.470.480.490.500.54
230.490.490.480.480.470.50
240.510.500.470.460.480.53
250.560.530.570.500.530.59
260.540.540.510.480.500.54